click below
click below
Normal Size Small Size show me how
APC Final
All of the drugs from this semester's BDK quizzes
| Definition | Term |
|---|---|
| alpha2 antagonist | mirtazapine pharmacologic category |
| remeron | mirtazapine brand name |
| MDD (major depressive disorder) | mirtazapine indication(s) |
| norepinephrine-dopamine reuptake inhibitor | burproprion pharmacologic category |
| Wellbutrin SR, Wellbutrin XL | buproprion brand name(s) |
| MDD (major depressive disorder) | buproprion indication(s) |
| selective norepinephrine reuptake inhibitor | atomoxetine pharmacologic category |
| strattera | atomoxetine brand name |
| ADHD | atomoxetine common indications |
| serotonin-norepinephrine reuptake inhibitor (SNRI) | desvenlafaxine pharmacologic category |
| pristiq | desvenlafaxine brand name |
| MDD (major depressive disorder) | desvenlafaxine common indicatoins |
| serotonin-norepinephrine reuptake inhibitor (SNRI) | duloxetine pharmacologic category |
| cymbalta | duloxetine brand name |
| MDD (major depressive disorder), neuropathic pain | duloxetine common indications |
| serotonin-norepinephrine reuptake inhibitor (SNRI) | venlafaxine pharmacologic category |
| effexor XR | venlafaxine brand name |
| MDD (major depressive disorder) | venlafaxine common indications |
| selective serotonin reuptake inhibitor (SSRI) | citalopram pharmacologic category |
| celexa | citalopram brand name |
| MDD (major depressive disorder) | citalopram common indications |
| selective serotonin reuptake inhibitor (SSRI) | fluoxetine pharmacologic category |
| prozac | fluoxetine brand name |
| MDD (major depressive disorder) | fluoxetine common indications |
| selective serotonin reuptake inhibitor (SSRI) | escitalopram pharmacologic category |
| lexapro | escitalopram brand name |
| MDD (major depressive disorder) | escitalopram common indications |
| selective serotonin reuptake inhibitor (SSRI) | paroxetine pharmacologic category |
| paxil | paroxetine brand name |
| MDD (major depressive disorder) | paroxetine common indications |
| selective serotonin reuptake inhibitor (SSRI) | sertraline pharmacologic category |
| zoloft | sertraline brand name |
| MDD (major depressive disorder) | sertraline common indications |
| serotonin reuptake inhibitor | trazadone pharmacologic category |
| desyrel | trazadone brand name |
| insomnia, MDD (major depressive disorder) | trazadone common indications |
| tricyclic antidepressant (TCA) | amitriptyline pharmacologic category |
| elavil | amitriptyline brand name |
| MDD (major depressive disorder), diabetic neuropathy, migraine prophylaxis | amitriptyline common indications |
| tricyclic antidepressant (TCA) | nortriptyline pharmacologic category |
| pamelor | nortriptyline brand name |
| MDD (major depressive disorder), diabetic neuropathy, migraine prophylaxis | nortriptyline common indications |
| tricyclic antidepressant (TCA) | doxepin pharmacologic category |
| silenor | doxepin brand name |
| insomnia | doxepin common indications |
| cns stimulant | dexmethylphenidate pharmacologic category |
| focalin, focalin XR | dexmethylphenidate brand name |
| ADHD | dexmethylphenidate common indications |
| cns stimulant | dextroamphetamine and amphetamine pharmacologic category |
| adderall, adderall XR | dextroamphetamine and amphetamine brand name |
| ADHD, narcolepsy | dextroamphetamine and amphetamine common indications |
| cns stimulant | lisdexamfetamine pharmacologic category |
| vyvanse | lisdexamfetamine brand name |
| ADHD | lisdexamfetamine common indications |
| cns stimulant | methylphenidate pharmacologic category |
| po: concerta, ritalin transdermal: daytrana | methylphenidate brand name |
| ADHD, narcolepsy | methylphenidate common indications |
| selective alpha2a agonist | guanfacine pharmacologic category |
| intuniv | guanfacine brand name |
| ADHD, hypertension | guanfacine common indications |
| dopamine agonist | pramipexole pharmacologic category |
| mirapex | pramipexole brand name |
| parkinson's disease, restless leg syndrome | pramipexole common indications |
| dopamine agoinst | ropinirole pharmacologic category |
| requip | ropinirole brand name |
| parkinson's disease, restless leg syndrome | ropinirole common indications |
| decarboxylase inhibitor, dopamine precursor | carbidopa and levodopa pharmacologic categories |
| sinemet, sinemet CR | carbidopa and levodopa brand name |
| parkinson's disease | carbidopa and levodopa common indications |
| n-methyl d-aspartate (NMDA) antagonist | memantine pharmacologic category |
| namenda | memantine brand name |
| dementia | memantine common indications |
| cholinesterase inhibitor | donepezil pharmacologic category |
| po: aricept transdermal: adlarity | donepezil brand name |
| dementia | donepezil common indications |
| antimanic agent | lithium pharmacologic category |
| lithobid | lithium brand name |
| bipolar disorder | lithium common indications |
| antimigraine | sumatriptan pharmacologic category |
| imitrex | sumatriptan brand name |
| migraine | sumatriptan common indications |
| antimigraine | rizatriptan pharmacologic category |
| maxalt | rizatriptan brand name |
| migraine | rizatriptan common indications |
| first-generation antipsychotic | haloperidol pharmacologic category |
| haldol | haloperidol brand name |
| schizophrenia | haloperidol common indications |
| second-generation antipsychotic | clozapine pharmacologic category |
| clozaril | clozapine brand name |
| treatment-resistant schizophrenia | clozapine common indications |
| second-generation antipsychotic | aripiprazole pharmacologic category |
| PO/IM: abilify IM: aristada | aripiprazole brand name |
| schizophrenia bipolar disorder MDD (adjunct to antidepressants) | aripiprazole common indications |
| second-generation antipsychotic | quetiapine pharmacologic category |
| seroquel, seroquel XR | quetiapine brand name |
| schizophrenia bipolar disorder MDD (adjunct to antidepressants) | quietiapine common indications |
| second-generation antipsychotic | lurasidone pharmacologic category |
| latuda | lurasidone brand name |
| schizophrenia bipolar disorder MDD (adjunct to antidepressants) | lurasidone common indications |
| second-generation antipsychotic | olanzapine pharmacologic category |
| zyprexa | olanzapine brand name |
| schizophrenia bipolar disorder MDD (adjunct to antidepressants) | olanzapine common indications |
| second-generation antipsychotic | risperidone pharmacologic category |
| PO: risperdal IM: risperdal, consta | risperidone brand name |
| schizophrenia | risperidone common indications |
| anticonvulsant | carbamazepine pharmacologic category |
| tegretol | carbamazepine brand name |
| seizure disorders, bipolar disorder | carbamazepine common indications |
| anticonvulsant | lamotrigine pharmacologic category |
| lamictal | lamotrigine brand name |
| seizure disorders, bipolar disorder | lamotrigine common indications |
| anticonvulsant | divalproex pharmacologic category |
| seizure disorders, bipolar disorder, migraine prophylaxis | divalproex common indications |
| depakote, depakote ER | divalproex brand name |
| anticonvulsant | topiramate pharmacologic category |
| topamax | topriamate brand name |
| seizure disorders, migraine prophylaxis | topriamate common indications |
| anticonvulsant | levetiracetam pharmacologic category |
| keppra | levetiracetam brand name |
| seizure disorders | levetiracetam common indications |
| anticonvulsant | gabapentin pharmacologic category |
| neurotin | gabapentin brand name |
| seizure disorders, neuropathic pain | gabapentin common indications |
| anticonvulsant | pregabalin pharmacologic category |
| lyrica | pregabalin brand name |
| seizure disorders, neuropathic pain | pregabalin common indications |
| CS-V | pregabalin classification |
| antianxiety agent | buspirone pharmacologic category |
| buspar | buspirone brand name |
| anxiety | buspirone common indications |
| benzodiazepine | alprazolam pharmacologic category |
| xanax | alprazolam brand name |
| anxiety | alprazolam common indications |
| benzodiazepine | clonazepam pharmacologic category |
| klonopin | clonazepam brand name |
| anxiety, seizure disorders | clonazepam common indications |
| benzodiazepine | diazepam pharmacologic category |
| valium | diazepam brand name |
| anxiety seizure disorders acute alcohol withdrawal | diazepam common indications |
| CS-IV | alprazolam classification |
| CS-IV | clonazepam classification |
| CS-IV | diazepam classification |
| benzodiazepine | lorazepam pharmacologic category |
| ativan | lorazepam brand name |
| anxiety seizure disorders acute alcohol withdrawal | lorazepam common indications |
| CS-IV | lorazepam classification |
| benzodiazepine | midazolam pharmacologic category |
| versed | midazolam brand name |
| anesthesia, sedation | midazolam common indications |
| CS-IV | midazolam classification |
| hypnotic | zolpidem pharmacologic category |
| PO: ambien, ambien CR SL: edluar | zolpidem brand name |
| insomnia | zolpidem common indications |
| sleep aid | melatonin pharmacologic category |
| no brand name | melatonin brand name |
| insomnia, jet lag | melatonin common indications |
| OTC | melatonin classification |
| sedative, general anesthetic | propofol pharmacologic category |
| dripivan | propofol brand name |
| sedation for mechanical ventilation procedural anesthesia status epilepticus | propofol common indications |
| alpha2 agonist sedative | dexmedetomidine pharmacologic category |
| precedex | dexmedetomidine brand name |
| sedation for mechanical ventilation or procedures | dexmedetomidine common indications |
| CS-IV | zolpidem classification |
| inhaled corticosteroid (ICS) | budesonide pharmacologic category |
| pumicort | budesonide brand name |
| asthma, COPD (chronic obstructive pulmonary disease) | budesonide common indications |
| inhaled corticosteroid (ICS) | fluticasone propionate pharmacologic category |
| flovent, arnuity | fluticasone propionate brand name |
| asthma, COPD | flucticasone propionate common indications |
| inhaled corticosteroid (ICS), long-acting beta2 agonist (LABA), and long-acting muscarinic antagonist (LAMA) | umeclidinium + vilanterol + fluticasone pharmacologic category |
| trelegy ellipta | umeclidinium + vilanterol + fluticasone brand name |
| asthma, COPD | umeclidinium + vilanterol + fluticasone common indications |
| inhaled corticosteroid (ICS) and long-acting beta2 agonist (LABA) | fluticasone and salmeterol pharmacologic category |
| advair, wixela | fluticasone and salmeterol brand name |
| asthma, COPD | fluticasone and salmeterol common indications |
| inhaled corticosteroid (ICS) and long-acting beta2 agonist (LABA) | budesonide and formoterol pharmacologic category |
| symbicort, breyna | budesonide and formoterol brand name |
| asthma, COPD | budesonide and formoterol common indications |
| inhaled corticosteroid (ICS) and long-acting beta2 agonist (LABA) | mometasone and formoterol pharmacologic category |
| dulera | mometasone and formoterol brand name |
| asthma, COPD | mometasone and formoterol common indications |
| long-acting muscarinic antagonist (LAMA) | tiotropium pharmacologic category |
| spiriva | tiotropium brand name |
| asthma, COPD | tiotropium common indications |
| short-acting beta2 agonist | albuterol pharmacologic category |
| proventil, ventolin, proair | albuterol brand name |
| asthma, COPD | albuterol common indications |
| leukotriene receptor antagonist | montelukast pharmacologic category |
| singulair | montelukast brand name |
| allergic rhinitis (seasonal allergies), asthma | montelukast common indications |
| partial nicotine agonist | varenicline pharmacologic category |
| chantix | varenicline brand name |
| smoking cessation | varenicline common indications |
| alpha2 agonist | tizanidine pharmacologic category |
| zanaflex | tizanidine brand name |
| spasticity (muscle stiffness) | tizanidine common indications |
| aminoquinolone | hydroxychloroquine pharmacologic category |
| plaquenil | hydroxychloroquine brand name |
| rheumatoid arthiritis systemic lupus erythematosus malaria | hydroxychloroquine common indications |
| NSAID | diclofenac (topical) pharmacologic category |
| voltaren gel | diclofenac (topical) brand name |
| osteoarthritis | diclofenac (topical) common indications |
| OTC | diclofenac (topical) classification |
| NSAID | diclofenac (PO) pharmacologic category |
| voltaren | diclofenac (PO) brand name |
| osteoarthritis rheumatoid arthiritis acute pain | diclofenac (PO) common indications |
| NSAID | ibuprofen pharmacologic category |
| motrin, advil | ibuprofen brand name |
| osteoarthritis rheumatoid arthiritis acute pain | ibuprofen common indications |
| OTC | ibuprofen classification |
| NSAID | meloxicam pharmacologic category |
| mobic | meloxicam brand name |
| osteoarthritis rheumatoid arthiritis acute pain | meloxicam common indications |
| NSAID | indomethacin pharmacologic category |
| indocin | indomethacin brand name |
| osteoarthritis rheumatoid arthiritis acute pain gout | indomethacin common indications |
| NSAID | naproxen pharmacologic category |
| naprosyn, anaprox, aleve | naproxen brand name |
| osteoarthritis rheumatoid arthiritis acute pain gout | naproxen common indications |
| OTC | naproxen classification |
| NSAID | ketorolac pharmacologic category |
| toradol | ketorolac brand name |
| pain | ketorolac common indications |
| NSAID, COX-2 selective | celecoxib pharmacologic category |
| celebrex | celecoxib brand name |
| osteoarthritis rheumatoid arthiritis acute pain | celecoxib common indications |
| skeletal muscle relaxant | cyclobenzaprine pharmacologic category |
| flexeril, amrix, fexmid | cyclobenzaprine brand name |
| muscle spams | cyclobenzaprine common indications |
| skeletal muscle relaxant | baclofen pharmacologic category |
| no brand name | baclofen brand name |
| spasticity (muscle stiffness) | baclofen common indications |
| skeletal muscle relaxant | methocarbamol pharmacologic category |
| robaxin | methocarbamol brand name |
| muscle spasm | methocarbamol common indications |
| transdermal: topical analgesic | lidocaine (topical) pharmacologic category |
| lidoderm | lidocaine (topical) brand name |
| pain | lidocaine (topical) common indications |
| IV: anti-arrhythmic | lidocaine (IV) pharmacologic category |
| xylocaine | lidocaine (IV) brand name |
| ventricular arrhythmias | lidocaine (IV) common indications |
| OTC | lidocaine (transdermal) classification |
| antigout agent | colchicine pharmacologic category |
| colcrys | colchicine brand name |
| gout | colchicine common indications |
| xanthine oxidase inhibitor | allopurinol pharmacologic category |
| zyloprim | allopurinol brand name |
| gout | allopurinol common indications |
| depolarizing neuromuscular blocking agent | succinylcholine pharmacologic category |
| anectine | succinylcholine brand name |
| neuromuscular blockade for intubation or procedures | succinylcholine common indication |
| anti-tumor necrosis factor alpha inhibitor | etanercept pharmacologic category |
| enbrel | etanercept brand name |
| rheumatoid arthiritis | etanercept common indications |
| anti-tumor necrosis factor alpha inhibitor | adalimumab pharmacologic category |
| humira | adalimumab brand name |
| rheumatoid arthiritis crohn's disease ulcerative colitis | adalimumab common indications |
| opioid analgesic | fentanyl pharmacologic category |
| transdermal: duragesic IV: sublimaze | fentanyl brand name |
| pain | fentanyl common indications |
| CS-II | fentanyl classification |
| opioid analgesic | hydromorphone pharmacologic category |
| dilaudid | hydromorphone brand name |
| pain | hydromorphone common indications |
| CS-II | hydromorphone classification |
| opioid analgesic | morphine ER pharmacologic category |
| ms contin, kadian | morphine ER brand name |
| pain | morphine ER common indications |
| CS-II | morphine ER classification |
| opioid analgesic | morphine IR pharmacologic category |
| IV: duramorph, infumorph | morphine IR brand name |
| pain | morphine IR common indications |
| CS-II | morphine IR classification |
| opioid analgesic | oxycodone pharmacologic category |
| oxycontin, roxicodone | oxycodone brand name |
| pain | oxycodone common indications |
| CS-II | oxycodone classification |
| opioid analgesic | methadone pharmacologic category |
| dolophine | methadone brand name |
| opioid use disorder, severe chronic pain | methadone common indications |
| CS-II | methadone classification |
| analgesic (non-opioid), antipyretic | acetaminophen pharmacologic category |
| PO/PR (per rectum): tylenol IV: ofirmev | acetaminophen brand name |
| pain, fever | acetaminophen common indications |
| PO/PR (per rectum): OTC | acetaminophen classification |
| central analgesic; partial opioid agonist | tramadol pharmacologic category |
| ultram, ultram ER | tramadol brand name |
| pain | tramadol common indications |
| CS-IV | tramadol classification |
| opioid and nonopioid analgesic combination | hydrocodone and acetaminophen pharmacologic category |
| lortab, vicodin, norco | hydrocodone and acetaminophen brand name |
| pain | hydrocodone and acetaminophen common indications |
| CS-II | hydrocodone and acetaminophen classification |
| opioid and nonopioid analgesic combination | oxycodone and acetaminophen pharmacologic category |
| percocet, endocet | oxycodone and acetaminophen brand name |
| pain | oxycodone and acetaminophen common indication |
| CS-II | oxycodone and acetaminophen classification |
| opioid and nonopioid analgesic combination | codeine and acetaminophen pharmacologic category |
| tylenol with codeine #3, tylenol with codeine #4 | codeine and acetaminophen brand name |
| pain | codeine and acetaminophen common indications |
| CS-III | codeine and acetaminophen classification |
| opioid antagonist | naloxone pharmacologic category |
| narcan nasal spray, zimhi | naloxone brand name |
| opioid overdose | naloxone common indications |
| OTC | narcan nasal spray classification |
| partial opioid agonist and opioid antagonist | buprenorphrine and naloxone pharmacologic category |
| suboxone | buprenorphrine and naloxone brand name |
| opioid use disorder | buprenorphrine and naloxone common indications |
| CS-III | buprenorphrine and naloxone classification |
| iron supplement | ferrous sulfate pharmacologic category |
| ferosul, slowfe | ferrous sulfate brand name |
| iron deficiency anemia | ferrous sulfate common indications |
| OTC | ferrous sulfate classification |
| water-soluble vitamin | cyanocobalamin (vitamin b12) pharmacologic category |
| no brand name | cyanocobalamin (vitamin b12) brand name |
| vitamin b12 deficiency (manifests as macrocytic anemia) | cyanocobalamin (vitamin b12) common indications |
| PO, SL: OTC | cyanocobalamin (vitamin b12) classification |
| water-soluble vitamin | folic acid pharmacologic category |
| no brand name | folic acid brand name |
| folic acid deficiency (manifests as macrocytic anemia), prevention of neural tube defects in pregnancy | folic acid common indications |
| OTC | folic acid classification |
| antimetabolite (folic acid antagonist) | methotrexate pharmacologic category |
| trexall | methotrexate brand name |
| rheumatoid arthiritis crohn's disease psoriasis varoius hematologic and solid tumors | methotrexate common indications |
| antineoplastic agent, anthracycline | cisplatin pharmacologic category |
| kemoplat | cisplatin brand name |
| advanced bladder ovarian and testicular cancer various cancers | cisplatin common indications |
| antineoplastic agent, antibody | doxorubicin pharmacologic category |
| adriamycin | doxorubicin brand name |
| adjuvant therapy for breast cancer, various cancers | doxorubicin common indications |
| antineoplastic agent, monoclonal antibody | pembrolizumab pharmacologic category |
| keytruda | pembrolizumab brand name |
| various cancers | pembrolizumab common indications |
| aromatase inhibitor | anastrozole pharmacologic category |
| arimidex | anastrozole brand name |
| horome receptor-positive breast cancer | anastrozole common indications |
| selective estrogen receptor modulator (SERM) | tamoxifen pharmacologic category |
| soltamox | tamoxifen pharmacologic category |
| hormone receptor-positive breast cancer | tamoxifen common indications |
| 5 alpha-reductase inhibitor | finasteride pharmacologic category |
| proscar, propecia | finasteride brand name |
| benign prostatic hyperplasia (BPH), male pattern baldness | finasteride common indications |
| alpha1 blocker | doxazosin pharmacologic category |
| cardura, cardura XL | doxazosin brand name |
| benign prostatic hyperplasia (BPH), hypertension | doxazosin common indications |
| alpha1a blocker | tamsulosin pharmacologic category |
| flomax | tamsulosin brand name |
| benign prostatic hyperplasia (BPH) | tamsulosin common indications |
| anticholingeric | solifenacin pharmacologic category |
| vesicare | solifenacin brand name |
| overactive bladder | solifenacin common indications |
| anticholingeric, urinary antispasmodic agent | oxybutynin pharmacologic category |
| PO: ditropan XL Patch: oxytrol, oxytrol for women | oxybutynin brand name |
| overactive bladder | oxybutynin common indications |
| Patch: OTC | oxybutynin (patch) classification |
| beta3 agonist | mirabegron pharmacologic category |
| mybetriq | mirabegron brand name |
| overactive bladder | mirabegron common indications |
| urinary analgesic | phenazopyridine pharmacologic category |
| pyridium, azo urinary pain relief | phenazopyridine brand name |
| symptomatic relief of dysuria | phenazopyridine common indications |
| OTC | phenazopyridine classification |
| electrolyte supplement | magnesium sulfate pharmacologic category |
| no brand name | magnesium sulfate brand name |
| hypomagnesemia, pre-eclampsia | magnesium sulfate common indications |
| electrolyte supplement | potassium chloride pharmacologic category |
| k-tab, klor-con, micro-k | potassium chloride brand name |
| hypokalemia | potassium chloride common indications |
| colloid | albumin 5% or 25% pharmacologic category |
| albutein, alburx | albumin 5% or 25% brand name |
| hypovolemia (critical decrease in body fluid/blood volume) spontaneous bacterial peritonitis (infection of ascitic fluid) paracentesis (remove excess fluid) | albumin 5% or 25% common indications |
| crystalloid | 0.9% sodium chloride pharmacologic category |
| normal saline | 0.9% sodium chloride brand name |
| hypovolemia | 0.9% sodium chloride common indications |
| crystalloid | lactated ringers pharmacologic category |
| LR | lactated ringers brand name |
| hypovolemia | lactated ringers common indications |
| crystalloid | 5% dextrose in water pharmacologic category |
| D5W | 5% dextrose in water brand name |
| carrier fluid hypoglycemia hypernatremia | 5% dextrose in water common indications |
| phosphate binder | calcium acetate pharmacologic category |
| calphron, phoslo | calcium acetate brand name |
| hyperphosphatemia | calcium acetate common indications |
| calphron: OTC | calcium acetate classification |
| angiotensin-converting enzyme (ACE) inhibitor | benazepril pharmacologic category |
| lotensin | benazepril brand name |
| hypertension (HTN) heart failure (HF) coronary artery disease (CAD) | benazepril common indications |
| angiotensin-converting enzyme (ACE) inhibitor | enalapril pharmacologic category |
| vasotec | enalapril brand name |
| hypertension (HTN) heart failure (HF) coronary artery disease (CAD) | enalapril common indications |
| angiotensin-converting enzyme (ACE) inhibitor | lisinopril pharmacologic category |
| prinivil, zestril | lisinopril brand name |
| hypertension (HF) heart failure (HF) coronary artery disease (CAD) | lisinopril common indications |
| angiotensin-converting enzyme (ACE) inhibitor | ramipril pharmacologic category |
| altace | ramipril brand name |
| hypertension (HTN) heart failure (HF) coronary artery disease (CAD) | ramipril common indications |
| angiotensin II receptor blocker (ARB) | irbesartan pharmacologic category |
| avapro | irbesartan brand name |
| hypertension (HTN) heart failure (HF) coronary artery disease (CAD) | irbesartan common indications |
| angiotensin II receptor blocker (ARB) | losartan pharmacologic category |
| cozaar | losartan brand name |
| hypertension (HTN) heart failure (HF) coronary artery disease (CAD) | losartan common indications |
| angiotensin II receptor blocker (ARB) | olmesartan pharmacologic category |
| benicar | olmesartan brand name |
| hypertension (HTN) heart failure (HF) coronary artery disease (CAD) | olmesartan common indications |
| angiotensin II receptor blocker (ARB) | valsartan pharmacologic category |
| diovan | valsartan brand name |
| hypertension (HTN) heart failure (HF) coronary artery disease (CAD) | valsartan common indications |
| Angiotensin II receptor blocker (ARB) and neprilysin inhibitor (ARNI) | valsartan and sacubitril pharmacologic category |
| entresto | valsartan and sacubitril brand name |
| heart failure | valsartan and sacubitril common indications |
| dihydropyridine calcium channel blocker (CCB) | amlodipine pharmacologic category |
| norvasc | amlodipine brand name |
| hypertension (HTN), coronary artery disease (CAD) | amlodipine common indications |
| dihydropyridine calcium channel blocker (CCB) | nifedipine pharmacologic category |
| procardia XL, adalat CC | nifedipine brand name |
| hypertension (HTN), coronary artery disease (CAD) | nifedipine common indications |
| dihyropyridine calcium channel blocker (CCB) | nicardipine pharmacologic category |
| cardene | nicardipine brand name |
| hypertensive crisis | nicardipine common indications |
| non-dihydropyridine calcium channel blocker (CCB) | diltiazem pharmacologic category |
| cartia XT, cardizem CD, caridem LA, cardizem, tiazac | diltiazem brand name |
| atrial fibrillation (rate control) hypertension (HTN) coronary artery disease (CAD) | diltiazem common indications |
| thiazide diuretic | hydrochlorothiazide pharmacologic category |
| no brand name | hydrochlorothiazide brand name |
| hypertension (HTN) | hydrochlorothiazide common indications |
| non-dihydropyridine calcium channel blocker (CCB) | verapamil pharmacologic category |
| calan SR, verelan | verapamil brand name |
| atrial fibrillation (AF) hypertension (HTN) coronary artery disease (CAD) | verapamil common indications |
| thiazide-related diuretic | chlorthalidone pharmacologic category |
| thalitone | chlorthalidone brand name |
| hypertension | chlorthalidone common indications |
| dihydropyridine CCB + ACE inhibitor | amlodipine and benazepril pharmacologic category |
| lotrel | amlodipine and benazepril brand name |
| hypertension (HTN) heart failure (HF) coronary artery disease (CAD) | amlodipine and benazepril common indications |
| ACE inhibitor + thiazide diuretic | lisinopril and hydrochlorothiazide pharmacologic category |
| zestoretic | lisinopril and hydrochlorothiazide brand name |
| hypertension (HTN) heart failure (HF) coronary artery disease (CAD) | lisinopril and hydrochlorothiazide common indications |
| ARB + thiazide diuretic | losartan and hydrochlorothiazide pharmacologic category |
| hypertension (HTN) heart failure (HF) coronary artery disease (CAD) | losartan and hydrochlorothiazide common indications |
| hyzaar | losartan and hydrochlorothiazide brand names |
| ARB + thiazide diuretic | olmesartan and hydrochlorothiazide pharmacologic category |
| benicar-HCT | olmesartan and hydrochlorothiazide brand name |
| hypertension (HTN) heart failure (HF) coronary artery disease (CAD) | olmesartan and hydrochlorothiazide common indications |
| ARB + thiazide diuretic | valsartan and hydrochlorothiazide pharmacologic category |
| diovan-HCT | valsartan and hydrochlorothiazide brand name |
| hypertension (HTN) heart failure (HF) coronary artery disease (CAD) | valsartan and hydrochlorothiazide common indications |
| mineralocorticoid receptor agonist (MRA) | spironolactone pharmacologic category |
| aldactone | spironolactone brand name |
| hypertension (HTN) heart failure (HF) ascites (fluid build up in the abdomen) | spironolactone common indications |
| loop diuretic | furosemide pharmacologic category |
| lasix | furosemide brand name |
| volume overload | furosemide common indications |
| loop diuretic | torsemide pharmacologic category |
| soaanz | torsemide brand name |
| volume overload | torsemide common indications |
| beta1-selective beta-blocker | atenolol pharmacologic category |
| tenormin | atenolol brand name |
| atrial fibrillation (AF) coronary artery disease(CAD) hypertension (HTN) | atenolol common indications |
| beta1-selective beta-blocker | metoprolol tartrate pharmacologic category |
| lopressor | metoprolol tartrate brand name |
| atrial fibrillation (AF) coronary artery disease (CAD) hypertension (HTN) | metoprolol tartrate common indications |
| beta1-selective beta-blocker | metoprolol succinate pharmacologic category |
| toprol-XL | metoprolol succinate brand name |
| heart failure (HF) afib coronary artery disease (CAD) hypertension (HTN) | metoprolol succinate common indications |
| beta1-selective beta blocker | nebivolol pharmacologic category |
| bystolic | nebivolol brand name |
| hypertension | nebivolol common indications |
| beta1-selective beta-blocker | esmolol pharmacologic category |
| brevibloc | esmolol brand name |
| hypertension (HTN) afib (AF) coronary artery disease (CAD) hypertension (HTN) | esmolol common indications |
| non-selective beta-blocker and alpha1 blocker | carvedilol pharmacologic category |
| coreg, coreg CR | carvedilol brand name |
| heart failure (HF) afib (AF) coronary artery disease (CAD) hypertension (HTN) | carvedilol common indications |
| non-selective beta-blocker and alpha1 blocker | labetalol pharmacologic category |
| trandate | labetalol brand name |
| PO: hypertension (HTN) IV: hypertensive crisis | labetalol common indications |
| non-selective beta-blocker | propanolol pharmacologic category |
| inderal LA, inderal XL | propanolol brand name |
| hypertension (HTN) coronary artery disease (CAD) migraine prohylaxis | propanolol common indications |
| alpha2 agonist | clonidine pharmacologic category |
| PO: catapres transdermal: catapres-TTS | clonidine brand name |
| hypertension (HTN), ADHD | clonidine common indication |
| direct arterial vasodilator | hydralazine pharmacologic category |
| no brand name | hydralazine brand name |
| hypertension | hydralazine common indication |
| beta1, beta2, and alpha 1 agonist | epinephrine pharmacologic class |
| adrenalin, epipen | epinephrine brand name |
| advanced cardiac life support shock anaphylaxis bradycardia | epinephrine common indications |
| alpha1 agonist (predominantly), beta 1 and beta2 agonist | norepinephrine pharmacologic category |
| levophed | norepinephrine brand name |
| shock | norepinephrine common indication |
| anticoagulant direct thrombin inhibitor | dabigatran pharmacologic category |
| pradaxa | dabigatran brand name |
| afib (AF) venous thromboembolism (VTE) | dabigatran common indications |
| anticoagulant factor Xa inhibitor | apixaban pharmacologic category |
| eliquis | apixaban brand name |
| afib (AF), venous thromboembolism (VTE) | apixaban common indications |
| anticoagulant factor Xa inhibitor | rivaroxaban pharmacologic category |
| xarelto | rivaroxaban brand name |
| afib (AF), venous thromboembolism (VTE) | rivaroxaban common indications |
| anticoagulant vitamin K antagonist | warfarin pharmacologic category |
| coumadin, jantoven | warfarin brand name |
| afib (AF) venous thromboembolism (VTE) | warfarin common indications |
| anticoagulant, low molecular weight heparin | enoxaparin pharmacologic category |
| lovenox | enoxaparin brand name |
| acute coronary syndrome (ACS), venous thromboembolism (VTE) | enoxaparin common indication |
| anticoagulant | heparin pharmacologic category |
| no brand name | heparin brand name |
| acute coronary syndrome (ACS), venous thromboembolism (VTE) | heparin common indication |
| antiplatelet agent | clopidogrel pharmacologic category |
| plavix | clopidogrel brand name |
| coronary artery disease (CAD), stroke | clopidogrel common indication |
| antiplatelet agent | ticagrelor pharmacologic category |
| brilinta | ticagrelor brand name |
| acute coronary syndrome (ACS) | ticagrelor common indication |
| antiplatelet agent | aspirin pharmacologic category |
| bayer, bufferin, ecotrin | aspirin brand name |
| acute coronary syndrome (ACS) stable angina pain stroke pain stroke | aspirin common indications |
| vasodilator | nitroglycerin pharmacologic category |
| acute coronary syndrome (ACS), stable angina | nitroglycerin common indications |
| nitrostat | nitroglycerin brand name |
| fibrinolytic | alteplase pharmacologic category |
| intracatheter: cathflo, activase IV: activase | alteplase brand name |
| intracatheter: catheter clearance IV: ST segment elevation myocardial infarction (STEMI), acute ischemic stroke, pulmonary embolism (PE) | alteplase common indications |
| antiarrhythmic | amiodarone pharmacologic category |
| pacerone, nexterone | amiodarone brand name |
| afib vfib ventricular tachycardia | amiodarone common indications |
| cholesterol absorption inhibitor | ezetimibe pharmacologic category |
| zetia | ezetimibe brand name |
| dyslipidemia | ezetimibe common indications |
| fibric acid derivative | fenofibrate pharmacologic category |
| tricor, trilipix | fenofibrate brand name |
| hypertriglyceridemia (high level of fat in the blood) | fenofibrate common indications |
| OTC | aspirin classification |
| HMG-CoA reductase inhibitor | atorvastatin pharmacologic category |
| lipitor | atorvastatin brand name |
| dyslipidemia coronary artery disease (CAD) stroke | atrovastatin common indications |
| fibric acid derivative | gemfibrozil pharmacologic category |
| lopid | gemfibrozil brand name |
| hypertriglyceridemia (high level of fat in the blood) | gemfibrozil common indications |
| HMG-CoA reductase inhibitor | lovastatin pharmacologic category |
| altoprev | lovastatin brand name |
| dyalipidemia coronary artery disease (CAD) stroke | lovastatin common indications |
| HMG-CoA reductase inhibitor | pravastatin pharmacologic category |
| pravachol | pravastatin brand name |
| dyslipidemia coronary artery disease (CAD) stroke | pravastatin common indications |
| HMG-CoA reductase inhibitor | rosuvastatin pharmacologic category |
| crestor | rosuvastatin brand name |
| dyslipidemia coronary artery disease (CAD) stroke | rosuvastatin common indications |
| HMG-CoA reductase inhibitor | simvastatin pharmacologic category |
| zocor | simvastatin brand name |
| dyslipidemia coronary artery disease (CAD) stroke | simvastatin common indications |
| omega-3 fatty acids | omega-3 ethyl esters pharmacologic category |
| lovaza | omega-3 ethyl esters brand name |
| hypertriglyceridemia (increased level of fats in the blood) | omega-3 ethyl esters common indication |
| omega-3 fatty acids | icosapent ethyl pharmacologic category |
| vascepa | icosapent ethyl brand name |
| hypertriglyceridemia (elevated levels of fats in the blood) | icosapent ethyl common indications |
| OTC | omega-3 ethyl esters classification |
| OTC | icosapent ethyl classification |